4 The weight-loss efficacy of tirzepatide in both diabetic and non-diabetic individuals has been shown in the SURMOUNT trials
a 3D avatar of yourself with the breakdown of Body Fat, Fat Mass, Lean Mass, Weight, Body Shape Rating, Posture check, Balance check, 12 Body Measurements, and Basal Metabolic Rate
0.22 m) immediately prior to use Aliquot and store reconstituted solutions at 20 C (or lower) to minimise degradation Avoid repeated freezethaw cycles
Theres no established human dosage in peer-reviewed literature
adult population meets the criteria to be clinically diagnosed as overweight, obese, or severely obese
This flat-rate pricing model removes the financial barrier to accessing genuine, personalized GLP-1 therapy that metformin cannot replicate